The Challenge:

There is a wide array of applications which require novel bioactive compounds for their products. Yet discovery of new compounds with specific requirements is very challenging, prohibitively expensive and inherently comprises high risk of late-stage development failure.

Current discovery methods are inefficient and have exhausted the known chemical space. They simply don’t possess the highly advanced tools required to satisfy the market's growing need for sustainable compounds.

Our Solution:

Agrematch harnesses AI-based data-science to revolutionize the discovery process of new bioactive compounds.

Agrematch has developed a revolutionary artificial intelligence (AI) system, called Agresense, for the rational prediction of compounds for desired applications. The Agresense data platform is a distinctive, first of its kind, compound-based system employing a proprietary algorithm stack which utilizes data science concepts (AI/ML), as well as biology and chemistry know-how, in its discovery process. The Agresense system will accelerate the time to market and reduce the total costs and risks in developing sustainable bioactive solutions.

By applying its advanced computational system, Agrematch can reveal molecules with biological activity (bioactive compounds) which were previously inaccessible by traditional discovery methods. To date, the company has proven the value and advantages of its technology by uncovering several active compounds and developed a robust in-house pipeline.

Agrematch’s discovery engine is applicable to a wide range of industries, including nutrition, alternative proteins, human health, and agriculture. The company is interested to expand its collaborative partnerships with key stakeholders from the both the Agtech and Foodtech sectors.